CellSearch System cleared for monitoring metastatic breast cancer

Armen Hareyan's picture
Advertisement

Metastatic breast cancer monitoring

Veridex, a Johnson & Johnson company, today announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch

Advertisement